Expression of dominant-negative mutant DP-1 blocks cell cycle progression in G1

Molecular and Cellular Biology

Volumn 16, Issue 7, 1996, Pages 3698-3706

  Wu, Chin Lee ^a,b   Classon, Marie ^a,b   Dyson, Nicholas ^a   Harlow, Ed ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; TRANSCRIPTION FACTOR E2F;

ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CONTROLLED STUDY; DIMERIZATION; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN CELL; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN DOMAIN; TRANSACTIVATION;

EID: 0030008768     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.16.7.3698     Document Type: Article

References (73)

1. Ausubel, F. M., R. Brent, R. E. Kington, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1988. Current protocols in molecular biology. Greene Publishing Associates & Wiley-Interscience, New York.
2. Bagchi, S., P. Raychaudhuri, and J. Nevins. 1990. Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation. Cell 62:659-669.
3. Baker, S. J., S. Markowitz, E. R. Fearon, J. K. V. Wilson, and B. Vogelstein. 1990. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912-915.
4. Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and N. B. La Thangue. 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317-4324.
5. Bandara, L. R., E. W.-R. Lam, T. S. Sorensen, M. Zamanian, K. Girling, and N. B. La Thangue. 1994. DP-1: a cell cycle-regulated and phosphorylated component of transcription factor DRTF1/E2F which is functionally important for recognition by pRB and the adenovirus E4 orf 6/7 protein. EMBO J. 13:3104-3114.
6. Bandara, L. R., and N. B. La Thangue. 1991. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor. Nature (London) 351:494-497.
7. Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and R. Bernards. 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680-2690.
8. Billaud, M., K. J. Isselbacher, and R. Bernards. 1993. A dominant-negative mutant of Max that inhibits sequence-specific DNA binding by Myc proteins. Proc. Natl. Acad. Sci. USA 90:2739-2743.
9. Brown, P. H., T. K. Chen, and M. J. Birrer. 1993. Mechanism of action of a dominant-negative mutant of c-Jun. Oncogene 9:790-799.
10. Chellappan, S., K. B. Kraus, B. Kroger, K. Monger, P. M. Howley, W. C. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and the human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
11. Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and R. A. Weinberg. 1993. Cell cycle-specific association of E2F with the p130 E2F-binding domain. Genes Dev. 7:2392-2404.
12. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
13. Dobrowolski, S. F., D. W. Stacey, M. L. Harter, J. T. Stine, and S. W. Hiebert. 1994. An E2F dominant negative mutant blocks E1A induced cell cycle progression. Oncogene 9:2605-2012.
14. Duronio, R. J., P. H. O'Farrell, J.-E. Xie, A. Brook, and N. Dyson. 1995. The transcription factor E2F is required for S phase during Drosophila embryogenesis. Genes Dev. 9:1445-1455.
15. Dynlacht, B. D., A. Brook, M. S. Dembski, L. Yenush, and N. Dyson. 1994. DNA-binding and trans-activation properties by Drosophila E2F and DP proteins. Proc. Natl. Acad. Sci. USA 91:6359-6363.
16. Dynlacht, B. D., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin-cdk2 complexes. Genes Dev. 8:1772-1786.
17. Flemington, E. K., S. H. Speck, and W. G. Kaelin, Jr. 1993. E2F-1 mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90: 6914-6918.
18. Gauthier-Rouviere, C., C. Qiu-Qiong, N. Lautredou, A. Fernandez, J.-M. Blanchard, and N. J. C. Lamb. 1993. Expression and purification of the DNA-binding domain of SRF: SRF-DB. a part of a DNA-binding protein which can act as a dominant negative mutant in vivo. Exp. Cell Res. 209: 208-215.
19. Ginsberg, D., C. Vairo, T. Chittenden, Z. X. Xiao, G. Xu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665-2679.
20. Girling, R., L. R. Bandara, E. Ormondroyd, E. W.-F. Lam, S. Kotecha, T. Mohun, and N. B. La Thangue. 1994. Molecular characterization of Xenopus laevis DP proteins. Mol. Biol. Cell 5:1081-1092.
21. Girling, R., J. F. Partridge, L. R. Bandara, N. Burden, N. F. Totty, J. J. Hsuan, and N. B. La Thangue. 1993. A new component of the transcription factor DRTF1/E2F. Nature (London) 362:83-87.
22. Hamel, P. A., R. M. Gill, R. A. Phillips, and B. L. Gallic. 1992. Transcriptional repression of the E2-containing promoters EllaE, c-myc, and RB1 by the product of the RBI gene. Mol. Cell. Biol. 12:3431-3438.
23. Harlow, E., and D. Lane. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Press, Cold Spring Harbor, N.Y.
24. Helin, K., and E. Harlow. 1993. The retinoblastoma protein as a transcriptional repressor. Trends Cell Biol. 3:43-46.
25. Helin, K., E. Harlow, and A. R. Fattaey. 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501-6508.
26. Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and A. R. Fattaey. 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337-350.
27. Helin, K., C. Wu, A. Fattaey, J. Lees, B. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7:1850-1861.
28. Herskowitz, I. 1987. Functional inactivation of genes by dominant negative mutations. Nature (London) 329:219-222.
29. Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. R. Nevins. 1992. The interaction of pRb with E2F inhibits the transcriptional activity of E2F. Genes Dev. 6:177-185.
30. Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. van 'T Veer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082-3089.
31. Hope, I. A., and K. Struhl. 1986. Functional dissection of a eukaryotic transcriptional activator protein. GCN4 of yeast. Cell 46:885-894.
32. Huber, H. E., G. Edwards, P. J. Goodhart, D. R. Patrick, P. S. Huang, M. Ivey-Hoyle, S. F. Barnett, A. Oliff, and D. C. Heimbrook. 1993. Transcription factor E2F binds DNA as a heterodimer. Proc. Natl. Acad. Sci. USA 90: 3525-3529.
33. Ivey-Hoyle, M., R. Conroy, H. Huber, P. Goodhart, A. Oliff, and D. C. Heinbrook. 1993. Cloning and characterization of E2F-2, a novel protein with the biochemical properties of transcription factor E2F. Mol. Cell. Biol. 13:7802-7812.
34. Johnson, D. G., J. K. Schwartz, W. D. Cress, and J. R. Nevins. 1993. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature (London) 365:349-352.
35. Jooss, K., E. W.-F. Lam, A. Bybee, R. Girlin, R. Muller, and N. B. La Thangue. 1995. Proto-oncogenic properties of the DP family of proteins. Oncogene 10:1529-1536.
36. Kaelin, W. G., Jr., W. Krek, W. R. Sellers, J. A. DeCaprio, F. Ajchenbaum, C. S. Fuchs, T. Chittenden, Y. Li, P. J. Farnham, M. A. Blanar, D. M. Livingston, and E. K. Flemington. 1992. Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties. Cell 70:351-364.
37. Kovesdi, I., R. Reichel, and J. R. Nevins. 1986. Identification of a cellular transcription factor involved in E1A trans-activation. Cell 45:219-228.
38. Krek, W., M. E. Ewen, S. Shirodkar, Z. Z. Arany, W. G. Kaelin, and D. Livingston. 1994. Negative regulation of the growth-promoting transcription factor E2F-I by a stably bound cyclin A-dependent protein kinase. Cell 78:161-172.
39. Krek, W., D. M. Livingston, and S. Shirodkar. 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557-1560.
40. La Thangue, N. B. 1994. DTRF1/E2f: an extending family of heteridimeric factors implicated in cell cycle control. Trends Biochem. Sci. 19:108-114.
41. La Thangue, N. B., and P. W. J. Rigby. 1987. An adenovirus E1A-like transcription factor is regulated during the differentiation of murine embryonal carcinoma stem cells. Cell 49:507-513.
42. Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and K. Helin. 1993. The retinoblastoma protein binds to a family of E2F transcription factors. Mol. Cell. Biol. 13:7813-7825.
43. Li, Y., J. E. Slansky, D. J. Myers, N. R. Drinkwater, W. G. Kaelin, and P. J. Farnham. 1994. Cloning, chromosomal location, and characterization of mouse E2F1. Mol. Cell. Biol. 14:1861-1869.
44. Logan, T. J., D. L. Evans, W. E. Mercer, M. A. Bjornsti, and D. J. Hall. 1995. Expression of a deletion mutant of the E2F transcription factor in fibroblasts lengthens S phase and increase sensitivity to S phase-specific toxin. Cancer Res. 55:2883-2891.
45. Logan, T. J., K. L. Jordan, and D. Hall. 1994. Altered shape and cell cycle characteristics of fibroblasts expressing the E2F1 transcription factor. Mol. Biol. Cell 5:667-678.
46. Miller, J. H., and W. S. Reznikoff (ed.). 1978. The operon, p. 31-88. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
47. Muller, R. 1995. Trends in genetics, vol. 11. Transcriptional regulation during the mammalian cell cycle. Elsevier Trends Journals, Cambridge.
48. Neuhold, L. A., and W. B. 1993. HLH forced dimers: tithering MyoD to E47 generates a dominant positive myogenic factor insulated from negative regulation by Id. Cell 74:1033-1042.
49. Nevins, J. R. 1992. E2F; a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
50. O'Connor, R. J., and P. Hearing. 1994. Mutually exclusive interaction of the adenovirus E4-6/7 protein and the retinoblastoma gene product with internal domains of E2F-1 and DP-1. J. Virol. 68:6848-6862.
51. Ohtani, K., and J. R. Nevins. 1994. Functional properties of a Drosophila homolog of the E2F1 gene. Mol. Cell. Biol. 14:1603-1612.
52. Pesce, S., and R. Benezra. 1993. The loop region of the helix-loop-helix protein Idl is critical for its dominant negative activity. Mol. Cell. Biol. 13:7874-7880.
53. Petrak, D., S. Memon, M. J. Birrer, J. D. Ashwell, and C. M. Zacharchuk. 1994. Dominant negative mutant of c-Jun inhibits NF-AT transcriptional activity and prevents IL-2 gene transcription. J. Immunol. 22:2046-2051.
54. Qin, X.-Q., T. Chittenden, D. Livingston, and W. G. Kaelin. 1992. Identification of a growth suppression domain within the retinoblastoma gene product. Genes Dev. 6:953-964.
55. Qin, X.-Q., D. M. Livingston, M. Ewen, W. R. Sellers, Z. Arany, and W. G. Kaelin. 1995. The transcription factor E2F-1 is a downstream target of RB action. Mol. Cell. Biol. 15:742-755.
56. Qin, X.-Q., D. M. Livingston, W. G. J. Kaelin, and P. Adams. 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918-10922.
57. Raychaudhuri, P., S. Bagchi, S. H. Devoto, V. B. Kraus, E. Moran, and J. R. Nevins. 1991. Domains of the adenovirus E1A protein that are required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev. 5:1200-1211.
58. Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and R. A. Weinberg. 1995. E2F-4 and E2F-5, two novel members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403-2407.
59. Schwarz, J. K., S. H. Devoto, E. J. Smith, S. P. Chellappan, L. Jakoi, and J. R. Nevins. 1993. Interactions of the p107 and Rb proteins with E2F during the cell proliferation response. EMBO J. 12:1013-1020.
60. Shan, B., and W.-H. Lee. 1994. Deregulated expression of E2F-I induces S-phase entry and leads to apoptosis. Mol. Cell. Biol. 14:8166-8173.
61. Shan, B., X. Zhu, P.-L. Chen, T. Durfee, Y. Yang, D. Sharp, and W.-H. Lee. 1992. Molecular cloning of cellular genes encoding retinoblastoma-associated proteins: identification of a gene with properties of the transcription factor E2F. Mol. Cell. Biol. 12:5620-5631.
62. Singh, P., S. H. Wong, and W. Hong. 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329-3338.
63. Templeton, D. J., S. H. Park, L. Lanier, and R. A. Weinberg. 1991. Non-functional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033-3037.
64. Vairo, G., D. M. Livingston, and D. Ginsberg. 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869-881.
65. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
66. Weinberg, R. A. 1992. The retinoblastoma gene and gene product. p. 43-57. In A. J. Levine (ed.), Tumour suppressor genes, the cell cycle and cancer. vol. 12. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
67. Weintraub, S. J., C. A. Prater, and D. C. Dean. 1992. Retinoblastoma protein swithches the E2F site from positive to negative element. Nature (London) 358:259-261.
68. Wu, C.-L., L. R. Zukerberg, C. Ngwu, E. Harlow, and J. A. Lees. 1995. In vivo association of E2F and DP family proteins. Mol. Cell. Biol. 15:2536-2546.
69. Wu, X., and A. J. Levine. 1994. p53 and E2F-1 cooperate to mediate apoptosis. Proc. Natl. Acad. Sci. USA 91:3602-3606.
70. Xu, G., D. M. Livingston, and W. Krek. 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357-1361.
71. Zamanian, M., and N. B. La Thangue. 1992. Adenovirus E1A prevents the retinoblastoma gene product from repressing the activity of a cellular transcription factor. EMBO J. 11:2603-2610.
72. Zhang, Y., and S. P. Chellappan. 1995. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 10:2085-2093.
73. Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and E. Harlow. 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111-1125.